Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy

Nephrology Dialysis Transplantation

Volumn 11, Issue 1, 1996, Pages 182-185

  Tamsma, J T ^a   Van Der Woude, F J ^a   Lemkes, H H P J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Albumin excretion rate; Diabetic nephropathy; Heparan sulphate; Low molecular weight heparin

Indexed keywords

ALBUMIN; ENOXAPARIN; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARAN SULFATE; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HEMATOMA; HEMODYNAMICS; HUMAN; MALE; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY EXCRETION;

EID: 0030071492     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027038     Document Type: Article

References (18)

1. Striker LJ, Peten EP, Elliot SJ, Doi T, Striker GE. Mesangial cell turnover: effect of heparin and peptide growth factors. Lab Invest 1991; 64: 446-456
2. Kanwar YS, Hascall VC, Farquhar MG. Partial characterization of newly synthesized proteoglycans isolated from the glomerular basement membrane. J Cell Biol 1981; 90. 527-532
3. Kanwar YS, Rosenzweig LJ, Clogging of the glomerular basemem membrane. J Cell Biol 1982, 13: 489-494
4. Rosenzweig LJ, Kanwar YS. Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin. Lab Invest 1982; 47. 177-184
5. Olgemoller B, Schwaabe S, Gerbitz KD, Schleicher ED. Elevated glucose decreases the content of a basement membrane associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells. Diabetologia 1992; 35: 183-186
6. Silbiger S, Crowley S, Shan Z, Brownlee M, Satriano J, Schlondorff D. Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge. Kidney Int 1993; 43: 853-864
7. Moran A, Brown DM, Kim Y, Klein DJ. Effects of IGF-I and glucose on protein and proteoglycan synthesis by human fetal mesangial cells in culture. Diabetes 1991; 40: 1346-1354
8. van Del NF, Verhagen NAM, Tamsma JT et al. Decreased production of heparan sulphate proteoglycan by cultured human glomerular visceral epithelial cells and human mesangial cells under hyperglycemic conditions. J Am Soc Nephrol 1993; 4: 806 (Abstract)
9. Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int 1992; 41: 1070-1080
10. Tamsma JT, van den Born J, Bruijn JA et al. Expression of glomerular extracellular matrix components in human diabetic nephropathy, decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 1994; 37: 313-320
11. Deckert T, Feldt Rasmussen B, Borch Johnsen K, Jensen T, Kofoed Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-226
12. Coffey AK, Karnovsky MJ. Heparin inhibits mesangial cell proliferation in habu-venom-induced glomerular injury. Am J Pathol 1985; 120: 248-255
13. Floege J, Eng E, Young BA, Couser WG, Johnson RJ. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 1993; 43: 369-380
14. Gambaro G, Cavazzana AO, Luzi P et al. Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 1992; 42: 285-291
15. Myrup B, Hansen PM, Jensen T et al. Effect of low-dose heparin on urinary albumin excretion in insulin dependent diabetes mellitus. Lancet 1995; 345: 421-422
16. Donker AJM, van der Hem GK, Sluiter WJ, Beekhuis H. A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 1977; 20: 97-103
17. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984; 74: 1143-1155
18. Gambaro G, Venturinin AP, Noonan DM et al. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int 1994; 46: 797-806